Location: Greenwich, CT
CIK: 0001842545 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 12, 2025
Total Value: $408M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | NATERA INC | 339,764 | $53.78M | 13.2% | $59.65 | +144.2% | COM | 632307104 |
| ARGX | ARGENX SE | 74,990 | $46.12M | 11.3% | $326.70 | — | SPONSORED ADR | 04016X101 |
| ILMN | ILLUMINA INC | 343,361 | $45.88M | 11.2% | $149.08 | -4.5% | COM | 452327109 |
| ICLR | ICON PLC | 209,190 | $43.87M | 10.8% | $215.58 | +8.3% | SHS | G4705A100 |
| INSM | INSMED INC | 513,700 | $35.47M | 8.7% | $38.78 | +85.7% | COM PAR $.01 | 457669307 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 419,212 | $27.55M | 6.8% | $83.40 | -19.7% | COM | 09061G101 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 627,600 | $26.4M | 6.5% | $46.05 | +7.7% | COM | 90400D108 |
| INSP | INSPIRE MED SYS INC | 136,603 | $25.32M | 6.2% | $205.43 | -5.5% | COM | 457730109 |
| DXCM | DEXCOM INC | 274,551 | $21.35M | 5.2% | $93.70 | -21.0% | COM | 252131107 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 155,000 | $21.16M | 5.2% | $134.81 | -8.3% | COM | 64125C109 |
| PRCT | PROCEPT BIOROBOTICS CORP | 233,089 | $18.77M | 4.6% | $34.93 | +144.6% | COM | 74276L105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 76,256 | $17.94M | 4.4% | $153.17 | +71.7% | COM | 02043Q107 |
| AGIO | AGIOS PHARMACEUTICALS INC | 330,830 | $10.87M | 2.7% | $35.66 | +31.7% | COM | 00847X104 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 21,802 | $7.693M | 1.9% | $178.94 | +105.4% | COM | 91307C102 |
| ISRG | INTUITIVE SURGICAL INC | 4,390 | $2.291M | 0.6% | $230.55 | +125.9% | COM NEW | 46120E602 |
| IMCR | IMMUNOCORE HLDGS PLC | 46,300 | $1.366M | 0.3% | $68.32 | — | ADS | 45258D105 |
| TMDX | TRANSMEDICS GROUP INC | 18,061 | $1.126M | 0.3% | $74.54 | +24.9% | COM | 89377M109 |
| GRAL | GRAIL INC | 53,124 | $948K | 0.2% | $16.22 | +0.2% | COM | 384747101 |